Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T.
Yokoo T, Wolfson T, Iwaisako K, Peterson MR, Mani H, Goodman Z, Changchien C, Middleton MS, Gamst AC, Mazhar SM, Kono Y, Ho SB, Sirlin CB. Yokoo T, et al. Among authors: Iwaisako K. Biomed Res Int. 2015;2015:387653. doi: 10.1155/2015/387653. Epub 2015 Sep 1. Biomed Res Int. 2015. PMID: 26421287 Free PMC article.
CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
Tamaki N, Hatano E, Taura K, Tada M, Kodama Y, Nitta T, Iwaisako K, Seo S, Nakajima A, Ikai I, Uemoto S. Tamaki N, et al. Among authors: Iwaisako K. Am J Physiol Gastrointest Liver Physiol. 2008 Feb;294(2):G498-505. doi: 10.1152/ajpgi.00482.2007. Epub 2008 Jan 3. Am J Physiol Gastrointest Liver Physiol. 2008. PMID: 18174271
Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.
Nishio T, Hu R, Koyama Y, Liang S, Rosenthal SB, Yamamoto G, Karin D, Baglieri J, Ma HY, Xu J, Liu X, Dhar D, Iwaisako K, Taura K, Brenner DA, Kisseleva T. Nishio T, et al. Among authors: Iwaisako K. J Hepatol. 2019 Sep;71(3):573-585. doi: 10.1016/j.jhep.2019.04.012. Epub 2019 May 7. J Hepatol. 2019. PMID: 31071368
Origin of myofibroblasts in liver fibrosis.
Brenner DA, Kisseleva T, Scholten D, Paik YH, Iwaisako K, Inokuchi S, Schnabl B, Seki E, De Minicis S, Oesterreicher C, Taura K. Brenner DA, et al. Among authors: Iwaisako K. Fibrogenesis Tissue Repair. 2012 Jun 6;5(Suppl 1):S17. doi: 10.1186/1755-1536-5-S1-S17. eCollection 2012. Fibrogenesis Tissue Repair. 2012. PMID: 23259769 Free PMC article.
Cell signals influencing hepatic fibrosis.
Cong M, Iwaisako K, Jiang C, Kisseleva T. Cong M, et al. Among authors: Iwaisako K. Int J Hepatol. 2012;2012:158547. doi: 10.1155/2012/158547. Epub 2012 Aug 29. Int J Hepatol. 2012. PMID: 22973518 Free PMC article.
Identification of small molecule activators of cryptochrome.
Hirota T, Lee JW, St John PC, Sawa M, Iwaisako K, Noguchi T, Pongsawakul PY, Sonntag T, Welsh DK, Brenner DA, Doyle FJ 3rd, Schultz PG, Kay SA. Hirota T, et al. Among authors: Iwaisako K. Science. 2012 Aug 31;337(6098):1094-7. doi: 10.1126/science.1223710. Epub 2012 Jul 12. Science. 2012. PMID: 22798407 Free PMC article.
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis.
Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, Benner C, Iwaisako K, Moore-Morris T, Scott B, Tsukamoto H, Evans SM, Dillmann W, Glass CK, Brenner DA. Kisseleva T, et al. Among authors: Iwaisako K. Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9448-53. doi: 10.1073/pnas.1201840109. Epub 2012 May 7. Proc Natl Acad Sci U S A. 2012. PMID: 22566629 Free PMC article.
Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist.
Iwaisako K, Haimerl M, Paik YH, Taura K, Kodama Y, Sirlin C, Yu E, Yu RT, Downes M, Evans RM, Brenner DA, Schnabl B. Iwaisako K, et al. Proc Natl Acad Sci U S A. 2012 May 22;109(21):E1369-76. doi: 10.1073/pnas.1202464109. Epub 2012 Apr 25. Proc Natl Acad Sci U S A. 2012. PMID: 22538808 Free PMC article.
What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
Iwaisako K, Brenner DA, Kisseleva T. Iwaisako K, et al. J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2(Suppl 2):65-8. doi: 10.1111/j.1440-1746.2011.07002.x. J Gastroenterol Hepatol. 2012. PMID: 22320919 Free PMC article. Review.
72 results
Jump to page
Feedback